Sotyktu

Indicated For

plaque psoriasis

About This Medication

# BMS Patient Connect Patient Guide: How to Get Sotyktu at Low Cost ## About This Program Bristol Myers Squibb (BMS) has launched **BMS Patient Connect**, a direct-to-patient program designed to make Sotyktu (deucravacitinib) more affordable and accessible. Beginning January 2026, eligible cash-pay patients can purchase Sotyktu directly through this platform at **more than 80% less than the current list price**, with medications delivered directly to their door across all 50 states and Puerto Rico. ## About Sotyktu (Deucravacitinib) Sotyktu is an oral prescription medication used to treat **moderate-to-severe plaque psoriasis** in adults who may benefit from systemic therapy (pills or injections that work throughout the body) or phototherapy (specialized ultraviolet light treatment). As a first-in-class tyrosine kinase 2 (TYK2) inhibitor, Sotyktu represents an important treatment option for patients with significant psoriasis who have not responded adequately to other therapies. Before starting Sotyktu, your healthcare provider will evaluate you for infections, tuberculosis (both active and latent), and liver function, as the medication requires monitoring for these conditions during treatment. ## Who Qualifies for BMS Patient Connect The program is designed for **eligible cash-pay U.S. patients** with a valid Sotyktu prescription. While specific income thresholds have not been publicly detailed, the program targets patients who: - Have a prescription for Sotyktu from their healthcare provider - Are U.S. residents (including all 50 states and Puerto Rico) - Are paying out-of-pocket for their medication (cash-pay patients) - Do not have insurance coverage or prefer to use this direct-purchase option The program emphasizes accessibility and transparency, allowing patients to see the full cost of their medication upfront with no hidden fees. ## Insurance Requirements BMS Patient Connect is specifically designed for **cash-pay patients**. This means the program is intended for patients who are: - Uninsured - Underinsured with high out-of-pocket costs - Choosing to pay directly rather than use insurance If you have active insurance coverage, you may want to explore your insurance plan's coverage options first. However, if your insurance has high deductibles or copayments, the BMS Patient Connect pricing (more than 80% off list price) may be more affordable than your insurance cost-sharing. ## How to Apply While the search results confirm the program's existence and benefits, specific application procedures, phone numbers, and online portals have not been publicly disclosed. To access BMS Patient Connect: 1. **Obtain a Prescription**: Work with your healthcare provider to get a prescription for Sotyktu 2. **Contact BMS**: Reach out to Bristol Myers Squibb directly through their patient support resources or visit their official website for BMS Patient Connect enrollment information 3. **Verify Eligibility**: Confirm you meet the cash-pay patient requirements 4. **Complete Enrollment**: Follow BMS's enrollment process to set up your account 5. **Place Your Order**: Order your medication through the platform with transparent pricing 6. **Receive Delivery**: Your medication will be shipped directly to your address The program also provides **patient support resources** to help you throughout your treatment journey. ## Timeline and Delivery BMS Patient Connect offers **direct shipping across all 50 states and Puerto Rico**. While specific processing times have not been publicly announced, the program emphasizes: - **Direct-to-door delivery**: Medications are shipped directly to your home - **Full transparency**: You'll see all costs upfront before purchasing - **Nationwide access**: Available everywhere in the U.S. For specific information about processing times and delivery schedules, contact BMS Patient Connect directly when you enroll. ## What Happens If Your Application Is Denied If you're denied access to BMS Patient Connect, consider these alternatives: - **Work with your healthcare provider** to explore other treatment options or psoriasis management strategies - **Check insurance coverage** if you have health insurance, as your plan may cover Sotyktu with copayment assistance - **Contact BMS patient support** to understand why you were denied and whether you can reapply - **Explore other patient assistance programs** that may be available through BMS or other organizations ## Important Safety Information Before starting Sotyktu, inform your healthcare provider if you: - Have active or latent tuberculosis - Have a history of serious infections - Have liver disease or elevated liver enzymes - Have muscle pain, weakness, or elevated CPK levels - Are taking other medications that may interact with Sotyktu During treatment, your healthcare provider will monitor you for: - Signs of new infections - Tuberculosis development - Muscle pain or weakness (rhabdomyolysis) - Liver enzyme changes - Elevated triglyceride levels ## Disclaimer This guide provides general information about BMS Patient Connect based on publicly available information as of January 2026. Program details, eligibility requirements, pricing, and procedures may change. For the most current and complete information about the program, including specific application procedures, income eligibility, required documentation, and enrollment steps, please contact Bristol Myers Squibb directly or visit their official website. Always consult with your healthcare provider before starting any new medication. This guide is not a substitute for professional medical advice.

Program information last verified: March 25, 2026